期刊文献+

胺碘酮与毛花甙C控制快速心房颤动伴充血性心力衰竭患者心室率即时效应及安全性的比较 被引量:2

A comparative study on the efficacy and safety of intravenous amiodarone and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart falure
原文传递
导出
摘要 目的 比较静脉应用胺碘酮与毛花甙C控制快速心房颤动 (简称房颤 )伴充血性心力衰竭(心衰 )患者心室率的即时效应及安全性。方法  4 6例房颤患者 ,心室率≥ 12 0次 /min ,心功能Ⅱ级以上(NYHA)。采用随机方式分组 ,分别静脉应用胺碘酮、毛花甙C。结果 胺碘酮、毛花甙C组控制房颤快速心室率的总有效率分别为 81 0 %和 60 9% (P <0 0 5 ) ;心室率平均下降幅度分别为 3 5 %和 2 5 % (P <0 0 1) ;平均起效时间分别为 (2 3 1± 8 2 )min和 (5 0 7± 10 4 )min (P <0 0 1)。胺碘酮组有 1例出现症状性低血压 ,1例出现Ⅰ°房室传导阻滞 ,无心衰加重表现。结论 静脉应用胺碘酮能迅速、安全。 Objective To evaluate the efficacy and safety of intravenous amiodarone and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive hear filure.Methods Forty six patients with rapid atrial fibrillation,ventricular rate≥120 beats/minute,cardiac function≥second grade(NYHA),were randomly divided into two groups.The two groups were introvenously administered amiodarone and lanatoside C,respectively.Results The total efficacy on controlling rapid atrial fibrillation was 81 0% and 60 9% in amiodarone group and lanatoside C groups,respectively.Ventricular rate decreased by 35% and 25%,respectively.The mean response time was (23 1±8 2)minutes and (50 7±10 4)minutes,respectively.In amiodarone group,one patient developed symptomatic hypotension,and one had the first degree atrioventricular conduct block without worsening of congestive heart failure.Conclusion Amiodarone is safe and rapid in the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart filure.
出处 《中华急诊医学杂志》 CAS CSCD 2003年第3期188-190,共3页 Chinese Journal of Emergency Medicine
关键词 胺碘酮 毛花甙C 快速心房颤动 充血性心力衰竭 心室率 即时效应 安全性 比较 Amiodarone Lanatoside C Atrial fibrillation Congestive heart failure Ventricular rate
  • 相关文献

参考文献6

  • 1Jordaens L,Trouerbach J,Calle P,et al.Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo[].European Heart Journal.1997
  • 2Clemo HF,Wood MA,Gilligan DM,et al.Intravenous amiodarone for acute heart rate control in the critically ill patients with atrial tachyarrhythmias[].The American Journal of Cardiology.1998
  • 3KhandA. U,Rankin AC,Kaye GC.Systematic review of the management of atrial fibrillation in patients with heart failure[].European Heart Journal.2000
  • 4MCrijins G. MPVan Den Berg,ICVan Gelder,et al.Management of atrial fibrillation in the setting of heart failure[].European Heart Journal.1997
  • 5Deedwaine PC,Singh BN,Ellenbogen KA,et al.Spontaneou conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation[].Circulation.1998
  • 6Levy S,Breithardt G,Fcarnpbell KW,et al.Atrial fibrillation: current knowledge and recommendation for management[].European Heart Journal.1998

同被引文献20

  • 1付丽娜.胺碘酮的副作用及其防治[J].医学理论与实践,2004,17(6):650-651. 被引量:8
  • 2Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the stroke council of the American Heart Association. Circulation, 2001, 103:163-182.
  • 3Laupacis A, Albers G, Dalen J, et al. Antithrombotic therapy in atrial fibrillation. Chest, 1998,114(5 Suppl):5795-5895.
  • 4Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. A multicenter, prospective, randomized trial. Stroke, 2000, 31:817-821.
  • 5Levy S, Brelthardt G, Campbell RW, et al. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J, 1998, 19:1294-1320.
  • 6Antiplatelet Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J, 2000, 324:71-86.
  • 7Hsievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation, 2002, 105:1887-1891.
  • 8Ezekowita MD, Levine JA. Preventing stoke in patients with atrial fibrillation. JAMA, 1999, 281: 1830-1835.
  • 9抗心律失常药物治疗专题组.抗心律失常药物治疗建议[J].中华心血管病杂志,2001,29(6):323-336. 被引量:788
  • 10蒋文平.胺碘酮的临床应用[J].中国心脏起搏与心电生理杂志,2001,15(5):289-290. 被引量:109

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部